The Motley Fool22d
Wall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
Analysts are bullish about Viking Therapeutics. Wall Street likes the company's promising pipeline, especially lead candidate VK-2735. Aggressive investors could find Viking Therapeutics stock ...